(COLM) Columbia Sportswear - Overview
Stock: Apparel, Footwear, Accessories, Equipment
| Risk 5d forecast | |
|---|---|
| Volatility | 33.2% |
| Relative Tail Risk | -5.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.43 |
| Alpha | -33.61 |
| Character TTM | |
|---|---|
| Beta | 1.052 |
| Beta Downside | 0.973 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.09% |
| CAGR/Max DD | -0.22 |
EPS (Earnings per Share)
Revenue
Description: COLM Columbia Sportswear January 12, 2026
Columbia Sportswear Company (NASDAQ: COLM) designs, develops, markets and distributes outdoor-apparel, footwear and equipment across the Americas, Europe, Asia-Pacific, the Middle East and Africa. Its product portfolio-hiking and trail-running apparel, cold-weather boots, fishing gear and lifestyle footwear-is sold through a mixed wholesale-to-retail model that includes specialty outdoor stores, large sporting-goods chains, department stores, e-commerce platforms and its own branded outlets, with brands that include Columbia, Mountain Hardwear, prAna and SOREL.
In FY 2023 the company reported roughly $4.3 billion in revenue, a 10 % year-over-year increase in e-commerce sales, and an operating margin of about 7 %, reflecting strong demand for outdoor recreation amid rising consumer confidence in discretionary spending. Inventory turnover improved to 3.2×, indicating better supply-chain efficiency, while the broader outdoor-apparel sector is benefitting from a post-pandemic “stay-active” trend that historically adds 3-4 % annual growth to category sales. However, exposure to raw-material price volatility and potential headwinds from inflation-driven cost pressures remain key risks to monitor.
For a deeper quantitative view of COLM’s valuation dynamics, you might explore the analyst tools on ValueRay to see how its forward-looking metrics compare to peers.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 177.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -7.09 > 1.0 |
| NWC/Revenue: 35.67% < 20% (prev 36.87%; Δ -1.21% < -1%) |
| CFO/TA 0.10 > 3% & CFO 282.9m > Net Income 177.2m |
| Net Debt (424.8m) to EBITDA (256.4m): 1.66 < 3 |
| Current Ratio: 2.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (53.7m) vs 12m ago -5.57% < -2% |
| Gross Margin: 50.53% > 18% (prev 0.50%; Δ 5003 % > 0.5%) |
| Asset Turnover: 115.1% > 50% (prev 113.2%; Δ 1.87% > 0%) |
| Interest Coverage Ratio: -0.69 > 6 (EBITDA TTM 256.4m / Interest Expense TTM -135.7m) |
Altman Z'' 6.32
| A: 0.41 (Total Current Assets 1.97b - Total Current Liabilities 760.8m) / Total Assets 2.93b |
| B: 0.59 (Retained Earnings 1.72b / Total Assets 2.93b) |
| C: 0.03 (EBIT TTM 93.9m / Avg Total Assets 2.95b) |
| D: 1.40 (Book Value of Equity 1.71b / Total Liabilities 1.22b) |
| Altman-Z'' Score: 6.32 = AAA |
Beneish M -3.16
| DSRI: 0.96 (Receivables 403.2m/417.5m, Revenue 3.40b/3.37b) |
| GMI: 0.99 (GM 50.53% / 50.20%) |
| AQI: 0.90 (AQ_t 0.09 / AQ_t-1 0.10) |
| SGI: 1.01 (Revenue 3.40b / 3.37b) |
| TATA: -0.04 (NI 177.2m - CFO 282.9m) / TA 2.93b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of COLM shares?
Over the past week, the price has changed by +0.35%, over one month by +14.35%, over three months by +16.93% and over the past year by -21.84%.
Is COLM a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 5
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the COLM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 64.5 | 1.9% |
| Analysts Target Price | 64.5 | 1.9% |
| ValueRay Target Price | 64.2 | 1.5% |
COLM Fundamental Data Overview February 12, 2026
P/E Forward = 20.3252
P/S = 1.0026
P/B = 1.9666
P/EG = 2.66
Revenue TTM = 3.40b USD
EBIT TTM = 93.9m USD
EBITDA TTM = 256.4m USD
Long Term Debt = 778.4m USD (estimated: total debt 866.9m - short term 88.5m)
Short Term Debt = 88.5m USD (from shortTermDebt, last quarter)
Debt = 866.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 424.8m USD (from netDebt column, last quarter)
Enterprise Value = 3.48b USD (3.41b + Debt 866.9m - CCE 790.8m)
Interest Coverage Ratio = -0.69 (Ebit TTM 93.9m / Interest Expense TTM -135.7m)
EV/FCF = 16.07x (Enterprise Value 3.48b / FCF TTM 216.7m)
FCF Yield = 6.22% (FCF TTM 216.7m / Enterprise Value 3.48b)
FCF Margin = 6.38% (FCF TTM 216.7m / Revenue TTM 3.40b)
Net Margin = 5.22% (Net Income TTM 177.2m / Revenue TTM 3.40b)
Gross Margin = 50.53% ((Revenue TTM 3.40b - Cost of Revenue TTM 1.68b) / Revenue TTM)
Gross Margin QoQ = 51.55% (prev 50.01%)
Tobins Q-Ratio = 1.19 (Enterprise Value 3.48b / Total Assets 2.93b)
Interest Expense / Debt = 0.48% (Interest Expense 4.13m / Debt 866.9m)
Taxrate = 22.59% (27.2m / 120.3m)
NOPAT = 72.7m (EBIT 93.9m * (1 - 22.59%))
Current Ratio = 2.59 (Total Current Assets 1.97b / Total Current Liabilities 760.8m)
Debt / Equity = 0.51 (Debt 866.9m / totalStockholderEquity, last quarter 1.71b)
Debt / EBITDA = 1.66 (Net Debt 424.8m / EBITDA 256.4m)
Debt / FCF = 1.96 (Net Debt 424.8m / FCF TTM 216.7m)
Total Stockholder Equity = 1.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.00% (Net Income 177.2m / Total Assets 2.93b)
RoE = 10.53% (Net Income TTM 177.2m / Total Stockholder Equity 1.68b)
RoCE = 3.82% (EBIT 93.9m / Capital Employed (Equity 1.68b + L.T.Debt 778.4m))
RoIC = 4.34% (NOPAT 72.7m / Invested Capital 1.67b)
WACC = 7.88% (E(3.41b)/V(4.27b) * Re(9.79%) + D(866.9m)/V(4.27b) * Rd(0.48%) * (1-Tc(0.23)))
Discount Rate = 9.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.65%
[DCF Debug] Terminal Value 70.78% ; FCFF base≈302.5m ; Y1≈198.6m ; Y5≈90.6m
Fair Price DCF = 25.72 (EV 1.81b - Net Debt 424.8m = Equity 1.39b / Shares 53.9m; r=7.88% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -3.65 | EPS CAGR: 14.83% | SUE: 2.21 | # QB: 1
Revenue Correlation: 14.19 | Revenue CAGR: 9.50% | SUE: 2.30 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.34 | Chg30d=-0.247 | Revisions Net=-3 | Analysts=7
EPS current Year (2026-12-31): EPS=3.41 | Chg30d=+0.432 | Revisions Net=+6 | Growth EPS=+5.2% | Growth Revenue=+1.6%
EPS next Year (2027-12-31): EPS=3.77 | Chg30d=+0.475 | Revisions Net=+4 | Growth EPS=+10.6% | Growth Revenue=+3.2%